#United States #Nutrition #Sacramento #One Bio #Plant Fiber

One Bio's Landmark Series A Funding

SACRAMENTO, CALIFORNIA — In a move set to reshape the nutritional landscape, One Bio has secured $27 million in Series A funding, primarily led by Alpha Edison and complemented by investors such as Leaps by Bayer and Mitsui E12. Founded with the mission of enhancing health through advanced nutrition, One Bio is revolutionizing the way we understand and consume dietary fiber by integrating it seamlessly into beloved food products.

Historically, the interaction between diet and health has been complex, yet modern eating habits, characterized by high sugar intake and drastically reduced fiber consumption, have worsened public health. Indeed, recent studies indicate that individuals today consume ten times more sugar than they did two centuries ago, while fiber intake has plummeted to a staggering 90% below evolutionary norms. This imbalance contributes significantly to the rising incidence of chronic diseases such as obesity and diabetes, echoing a crisis that demands innovative solutions.

A Technological Breakthrough

At the heart of One Bio’s technology is an innovative method that extracts anti-inflammatory short-chain fibers from a diverse array of plants, including seeds, fruits, vegetables, and grains. This enables high doses of fiber to be incorporated into foods without altering their flavor or texture, making it undetectable yet powerfully effective. The company's approach aims not only to mask the traditional barriers to fiber consumption but also to recast fiber as a crucial, yet virtually invisible ingredient in our daily diets.

Matt Barnard, co-founder and CEO of One Bio, emphasized the dire necessity for reintroducing plant fibers into the diet, remarking, “Modern food processing techniques strip plant fibers from our foods and starve the microbiome of the nutrients it needs to make us healthy.” He outlined that with the prevalence of processed foods contributing to 70% of our caloric intake, it is imperative to restore nutrient diversity to promote a balanced microbiome, which plays a vital role in various bodily functions including blood glucose regulation.

A Response to the Public Health Crisis

The funding season has not only validated One Bio’s revolutionary approach but has also cultivated a diverse group of investors who share the vision for enhancing global health through nutrition. These strategic collaborations could potentially expand the reach of their technology into mainstream markets, enabling a transformation in how consumers engage with food.

“In light of the health crises surrounding chronic diseases, consumers are becoming increasingly aware of the impact their diet has on their overall well-being,” noted Nate Redmond, a representative of Alpha Edison. He highlighted that One Bio is strategically positioned to tap into the growing demand for functional foods that support gut health while combating the adverse effects of processed diets.

Looking Ahead

As One Bio aims to disrupt the market, their vision is clear: to empower individuals through nutritional advancements that address malnutrition in modern living. With their cutting-edge technology paving the way for a new category of healthful products, One Bio is set to spearhead a paradigm shift in how we perceive and consume dietary fiber.

In conclusion, One Bio’s successful funding round signifies not just a financial boost but a pivotal leap towards fostering a health-conscious future. By addressing the fundamental flaws in our modern diet, they may very well play a crucial role in mitigating the rising tide of inflammation and chronic diseases that threaten public health today.

For more information, visit One Bio’s website.